Evermed Corporation – Trademark Portfolio

Entity Type: 03

Evermed Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 12 (Vehicles) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BROVIAC and HICKMAN. The owner is based in Medina, WA.

P.O. Box 296

Medina, WA 98039

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EVERMED
EVERMED
Cancelled 2001
HICKMAN
HICKMAN
Registered 1980
BROVIAC
BROVIAC
Registered 1980
EVERMED
EVERMED
Cancelled 1980

Trademark Classifications

Evermed Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Evermed Corporation have?

Evermed Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does Evermed Corporation file in?

Evermed Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 12 (Vehicles). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Evermed Corporation's most well-known trademarks?

Evermed Corporation's registered trademark portfolio includes well-known marks such as BROVIAC and HICKMAN. These are among 2 currently registered trademarks in the portfolio.

What is Evermed Corporation's trademark registration success rate?

Evermed Corporation has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.